A causal role for E-cadherin in the transition from adenoma to carcinoma

Development of malignant tumours is in part characterized by the ability of a tumour cell to overcome cell–cell adhesion and to invade surrounding tissue. E-cadherin is the main adhesion molecule of epithelia and it has been implicated in carcinogenesis because it is frequently lost in human epithelial cancers. Re-establishing the functional cadherin complex in tumour cell lines results in a reversion from an invasive to a benign epithelial phenotype. However, it remained unresolved whether the loss of E-cadherin-mediated cell adhesion was a cause or a consequence of tumour progression in vivo. Here we report that the loss of E-cadherin expression coincides with the transition from well differentiated adenoma to invasive carcinoma in a transgenic mouse model of pancreatic β-cell carcinogenesis (Rip1Tag2). Intercrossing Rip1Tag2 mice with transgenic mice that maintain E-cadherin expression in β-tumour cells results in arrest of tumour development at the adenoma stage, whereas expression of a dominant-negative form of E-cadherin induces early invasion and metastasis. The results demonstrate that loss of E-cadherin-mediated cell adhesion is one rate-limiting step in the progression from adenoma to carcinoma.

[1]  B. Herrmann,et al.  Nuclear localization of β-catenin by interaction with transcription factor LEF-1 , 1996, Mechanisms of Development.

[2]  Cadherins regulate aggregation of pancreatic beta-cells in vivo. , 1996, Development.

[3]  M. Takeichi Morphogenetic roles of classic cadherins. , 1995, Current opinion in cell biology.

[4]  W. Birchmeier,et al.  Molecular mechanisms leading to cell junction (cadherin) deficiency in invasive carcinomas. , 1993, Seminars in cancer biology.

[5]  H. Aberle,et al.  Cadherin‐catenin complex: Protein interactions and their implications for cadherin function , 1996, Journal of cellular biochemistry.

[6]  D. Hanahan,et al.  Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes. , 1985, Nature.

[7]  Paul Polakis,et al.  Stabilization of β-Catenin by Genetic Defects in Melanoma Cell Lines , 1997, Science.

[8]  W. Birchmeier,et al.  Mechanisms Identified in the Transcriptional Control of Epithelial Gene Expression (*) , 1996, The Journal of Biological Chemistry.

[9]  D. Hanahan,et al.  Molecular cloning of mouse pancreatic islet R-cadherin: differential expression in endocrine and exocrine tissue. , 1993, Molecular endocrinology.

[10]  Hans Clevers,et al.  Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC , 1997, Science.

[11]  C. Bierkamp,et al.  Cadherins and catenins in development. , 1996, Current opinion in cell biology.

[12]  D. Hanahan,et al.  Induction of angiogenesis during the transition from hyperplasia to neoplasia , 1989, Nature.

[13]  W. Birchmeier,et al.  Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. , 1994, Biochimica et biophysica acta.

[14]  Hans Clevers,et al.  XTcf-3 Transcription Factor Mediates β-Catenin-Induced Axis Formation in Xenopus Embryos , 1996, Cell.

[15]  Michael Kühl,et al.  Functional interaction of β-catenin with the transcription factor LEF-1 , 1996, Nature.

[16]  B. Gumbiner,et al.  Carcinogenesis: A balance between β-catenin and APC , 1997, Current Biology.

[17]  D. Hanahan,et al.  A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis , 1994, Nature.

[18]  K. Kinzler,et al.  Constitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC−/− Colon Carcinoma , 1997, Science.

[19]  B. Hogan,et al.  Manipulating the mouse embryo: A laboratory manual , 1986 .

[20]  D. Hanahan,et al.  The rise and fall of apoptosis during multistage tumorigenesis: down-modulation contributes to tumor progression from angiogenic progenitors. , 1996, Genes & development.

[21]  R. Moon,et al.  Signal transduction through beta-catenin and specification of cell fate during embryogenesis. , 1996, Genes & development.

[22]  W. Fiers,et al.  Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role , 1991, Cell.

[23]  D. Hanahan,et al.  Vascular endothelial growth factor and its receptors, flt-1 and flk-1, are expressed in normal pancreatic islets and throughout islet cell tumorigenesis. , 1995, Molecular endocrinology.

[24]  J. Herman,et al.  E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. , 1995, Cancer research.

[25]  M. Takeichi Cadherins in cancer: implications for invasion and metastasis. , 1993, Current opinion in cell biology.

[26]  S. Hirohashi,et al.  Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[27]  D. Hanahan,et al.  Proliferation, senescence, and neoplastic progression of β cells in hyperplasic pancreatic islets , 1988, Cell.